Of note, El-Helkan et al. found the UCA1 expression to be markedly upregulated in the plasma of non-metastatic BC (NMBC) patients, while also discovering the considerable downregulation of UCA1 in left breast tumors of metastatic BC patients (MBC), indicating its significant association with laterality in MBC [2]. This evidence concerns the gene UCA1 and breast cancer.